vs
Metagenomi, Inc.（MGX）与Rocky Mountain Chocolate Factory, Inc.（RMCF）财务数据对比。点击上方公司名可切换其他公司
Rocky Mountain Chocolate Factory, Inc.的季度营收约是Metagenomi, Inc.的1.9倍（$7.5M vs $3.9M），Rocky Mountain Chocolate Factory, Inc.净利率更高（-2.1% vs -576.0%，领先574.0%），Rocky Mountain Chocolate Factory, Inc.同比增速更快（-4.4% vs -59.3%），Rocky Mountain Chocolate Factory, Inc.自由现金流更多（$-1.3M vs $-23.6M），过去两年Rocky Mountain Chocolate Factory, Inc.的营收复合增速更高（1.9% vs -40.8%）
Metagenomi是一家临床阶段生物技术企业，专注于开发宏基因组技术驱动的基因编辑疗法。公司依托大规模微生物基因组数据集挖掘新型精准CRISPR及其他基因编辑工具，布局针对罕见病与常见遗传病的体内、体外基因治疗管线，面向全球生物制药市场运营。
落基山巧克力厂是美国知名巧克力企业，同时开展国际特许经营业务，集糖果生产与零售运营于一体，总部位于美国科罗拉多州杜兰戈，除美国本土门店外，在巴拿马、菲律宾也设有经营网点。
MGX vs RMCF — 直观对比
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $3.9M | $7.5M |
| 净利润 | $-22.5M | $-155.0K |
| 毛利率 | — | 34.0% |
| 营业利润率 | -623.0% | 1.1% |
| 净利率 | -576.0% | -2.1% |
| 营收同比 | -59.3% | -4.4% |
| 净利润同比 | 3.7% | 81.7% |
| 每股收益（稀释后） | $-0.59 | $-0.02 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $3.9M | $7.5M | ||
| Q3 25 | $8.7M | $6.8M | ||
| Q2 25 | $8.5M | $6.4M | ||
| Q1 25 | $4.1M | $8.9M | ||
| Q4 24 | $9.6M | $7.9M | ||
| Q3 24 | $11.5M | $6.4M | ||
| Q2 24 | $20.0M | $6.4M | ||
| Q1 24 | $11.2M | $7.3M |
| Q4 25 | $-22.5M | $-155.0K | ||
| Q3 25 | $-20.4M | $-662.0K | ||
| Q2 25 | $-19.9M | $-324.0K | ||
| Q1 25 | $-25.0M | $-2.9M | ||
| Q4 24 | $-23.4M | $-847.0K | ||
| Q3 24 | $-18.8M | $-722.0K | ||
| Q2 24 | $-10.7M | $-1.7M | ||
| Q1 24 | $-25.1M | $-1.6M |
| Q4 25 | — | 34.0% | ||
| Q3 25 | — | 23.6% | ||
| Q2 25 | — | 31.1% | ||
| Q1 25 | — | 10.8% | ||
| Q4 24 | — | 23.4% | ||
| Q3 24 | — | 31.8% | ||
| Q2 24 | — | 12.8% | ||
| Q1 24 | — | 24.3% |
| Q4 25 | -623.0% | 1.1% | ||
| Q3 25 | -263.8% | -7.0% | ||
| Q2 25 | -246.5% | -2.3% | ||
| Q1 25 | -674.1% | -30.3% | ||
| Q4 24 | -214.5% | -8.9% | ||
| Q3 24 | -194.4% | -14.3% | ||
| Q2 24 | -84.3% | -25.4% | ||
| Q1 24 | -260.2% | -21.7% |
| Q4 25 | -576.0% | -2.1% | ||
| Q3 25 | -235.5% | -9.7% | ||
| Q2 25 | -233.9% | -5.1% | ||
| Q1 25 | -606.7% | -32.5% | ||
| Q4 24 | -243.4% | -10.7% | ||
| Q3 24 | -163.0% | -11.3% | ||
| Q2 24 | -53.7% | -25.9% | ||
| Q1 24 | -225.4% | -21.9% |
| Q4 25 | $-0.59 | $-0.02 | ||
| Q3 25 | $-0.55 | $-0.09 | ||
| Q2 25 | $-0.54 | $-0.04 | ||
| Q1 25 | $-0.68 | $-0.38 | ||
| Q4 24 | $-0.37 | $-0.11 | ||
| Q3 24 | $-0.51 | $-0.11 | ||
| Q2 24 | $-0.29 | $-0.26 | ||
| Q1 24 | $-1.19 | $-0.25 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $41.7M | $641.0K |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $158.6M | $6.0M |
| 总资产 | $221.1M | $20.7M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | $41.7M | $641.0K | ||
| Q3 25 | $32.8M | $2.0M | ||
| Q2 25 | $26.9M | $893.0K | ||
| Q1 25 | $29.2M | $720.0K | ||
| Q4 24 | $27.4M | $1.1M | ||
| Q3 24 | $25.1M | $973.0K | ||
| Q2 24 | $61.2M | $637.0K | ||
| Q1 24 | $102.6M | $2.1M |
| Q4 25 | $158.6M | $6.0M | ||
| Q3 25 | $178.4M | $6.1M | ||
| Q2 25 | $195.8M | $6.7M | ||
| Q1 25 | $212.7M | $7.0M | ||
| Q4 24 | $234.9M | $9.8M | ||
| Q3 24 | $255.8M | $10.5M | ||
| Q2 24 | $269.4M | $9.0M | ||
| Q1 24 | $275.6M | $10.6M |
| Q4 25 | $221.1M | $20.7M | ||
| Q3 25 | $247.9M | $22.3M | ||
| Q2 25 | $272.3M | $20.1M | ||
| Q1 25 | $297.9M | $21.2M | ||
| Q4 24 | $324.6M | $21.6M | ||
| Q3 24 | $358.3M | $21.1M | ||
| Q2 24 | $385.9M | $19.0M | ||
| Q1 24 | $415.4M | $20.6M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-23.5M | $-1.2M |
| 自由现金流经营现金流 - 资本支出 | $-23.6M | $-1.3M |
| 自由现金流率自由现金流/营收 | -604.2% | -16.9% |
| 资本支出强度资本支出/营收 | 2.2% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-89.5M | — |
8季度趋势，按日历期对齐
| Q4 25 | $-23.5M | $-1.2M | ||
| Q3 25 | $-21.3M | $-488.0K | ||
| Q2 25 | $-21.3M | $350.0K | ||
| Q1 25 | $-22.8M | $1.2M | ||
| Q4 24 | $-26.3M | $-2.1M | ||
| Q3 24 | $-26.6M | $-3.5M | ||
| Q2 24 | $-26.3M | $-2.2M | ||
| Q1 24 | $-29.9M | $129.0K |
| Q4 25 | $-23.6M | $-1.3M | ||
| Q3 25 | $-21.3M | $-544.0K | ||
| Q2 25 | $-21.4M | $182.0K | ||
| Q1 25 | $-23.1M | — | ||
| Q4 24 | $-26.6M | — | ||
| Q3 24 | $-27.8M | $-4.6M | ||
| Q2 24 | $-27.0M | $-2.6M | ||
| Q1 24 | $-30.8M | $-352.3K |
| Q4 25 | -604.2% | -16.9% | ||
| Q3 25 | -246.3% | -8.0% | ||
| Q2 25 | -251.1% | 2.9% | ||
| Q1 25 | -560.5% | — | ||
| Q4 24 | -276.8% | — | ||
| Q3 24 | -241.8% | -72.6% | ||
| Q2 24 | -134.8% | -40.2% | ||
| Q1 24 | -275.7% | -4.9% |
| Q4 25 | 2.2% | 0.5% | ||
| Q3 25 | 0.9% | 0.8% | ||
| Q2 25 | 1.5% | 2.6% | ||
| Q1 25 | 7.0% | — | ||
| Q4 24 | 3.5% | — | ||
| Q3 24 | 10.4% | 17.5% | ||
| Q2 24 | 3.3% | 6.5% | ||
| Q1 24 | 8.2% | 6.6% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MGX
暂无分部数据
RMCF
| Manufacturing | $5.9M | 78% |
| Transferred At Point In Time | $1.2M | 16% |
| Other | $414.0K | 5% |
